Terms: = Lymphoma AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Prognosis
20 results:
1. Activation recovery interval as an electrocardiographic repolarization index to detect doxorubicin-induced cardiotoxicity.
Kinoshita T; Onda N; Ohno R; Ikeda T; Sugizaki Y; Ohara H; Nakagami T; Yuzawa H; Shimada H; Shimizu K; Ikeda T
J Cardiol; 2023 Dec; 82(6):473-480. PubMed ID: 37506822
[TBL] [Abstract] [Full Text] [Related]
2. The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren's syndrome: a single-centre, retrospective cohort study.
Mayer M; Martinic M; Reihl-Crnogaj M; Anic B
Rheumatol Int; 2023 Nov; 43(11):2031-2036. PubMed ID: 37491526
[TBL] [Abstract] [Full Text] [Related]
3. Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy.
Li M; Mi L; Wang C; Wang X; Zhu J; Qi F; Yu H; Ye Y; Wang D; Cao J; Hu D; Yang Q; Zhao D; Ma T; Song Y; Zhu J
BMC Med; 2022 Oct; 20(1):369. PubMed ID: 36280874
[TBL] [Abstract] [Full Text] [Related]
4. Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular lymphoma and Diffuse Large B-Cell lymphoma.
Qu Z; Zhang T; Gao F; Gong W; Cui Y; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Li L; Wang X; Zhang H
Biomed Res Int; 2022; 2022():4379556. PubMed ID: 35655476
[TBL] [Abstract] [Full Text] [Related]
5. Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment.
Sharma R; Jain A; Jandial A; Lad D; Khadwal A; Prakash G; Nada R; Aggarwal R; Ramachandran R; Varma N; Malhotra P
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):626-634. PubMed ID: 35610119
[TBL] [Abstract] [Full Text] [Related]
6. Upregulation of
Eshibona N; Giwa A; Rossouw SC; Gamieldien J; Christoffels A; Bendou H
Leuk Lymphoma; 2022 Aug; 63(8):1897-1906. PubMed ID: 35249471
[TBL] [Abstract] [Full Text] [Related]
7. Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.
Chen W; Liang W; He Y; Liu C; Chen H; Lv P; Yao Y; Zhou H
Med Oncol; 2022 Jan; 39(4):44. PubMed ID: 35092504
[TBL] [Abstract] [Full Text] [Related]
8. Clinical, Histologic, and Molecular Characteristics of Anaplastic lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell lymphoma.
Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
[TBL] [Abstract] [Full Text] [Related]
9. Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group.
Eichenauer DA; Plütschow A; Fuchs M; Sasse S; Baues C; Böll B; von Tresckow B; Diehl V; Borchmann P; Engert A
J Clin Oncol; 2020 Mar; 38(7):698-705. PubMed ID: 31626571
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis.
Migdady Y; Barnard J; Al Ali N; Steensma DP; DeZern A; Roboz G; Garcia-Manero G; Sekeres MA; Komrokji RS
Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):528-532. PubMed ID: 29937400
[TBL] [Abstract] [Full Text] [Related]
11. First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group.
Arranz R; García-Noblejas A; Grande C; Cannata-Ortiz J; Sánchez JJ; García-Marco JA; Aláez C; Pérez-Calvo J; Martínez-Sánchez P; Sánchez-González B; Canales MA; Conde E; Martín A; Arranz E; Terol MJ; Salar A; Caballero D
Haematologica; 2013 Oct; 98(10):1563-70. PubMed ID: 23753021
[TBL] [Abstract] [Full Text] [Related]
12. Intracellular disposition of methotrexate in acute lymphoblastic leukemia in children.
de Beaumais TA; Jacqz-Aigrain E
Curr Drug Metab; 2012 Jul; 13(6):822-34. PubMed ID: 22571483
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma.
Li C; Takino H; Eimoto T; Ishida T; Inagaki A; Ueda R; Suzuki R; Yoshino T; Nakagawa A; Nakamura S; Inagaki H
Mod Pathol; 2007 Jun; 20(6):648-55. PubMed ID: 17464320
[TBL] [Abstract] [Full Text] [Related]
14. Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells.
Armstrong F; Duplantier MM; Trempat P; Hieblot C; Lamant L; Espinos E; Racaud-Sultan C; Allouche M; Campo E; Delsol G; Touriol C
Oncogene; 2004 Aug; 23(36):6071-82. PubMed ID: 15208656
[TBL] [Abstract] [Full Text] [Related]
15. [Anaplastic large-cell lymphoma: review].
Kodet R; Mrhalová M; Krsková L; Stejskalová E
Cesk Patol; 2003 Jul; 39(3):102-14. PubMed ID: 14631806
[TBL] [Abstract] [Full Text] [Related]
16. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
Ohshima K; Suzumiya J; Kikuchi M
Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
[TBL] [Abstract] [Full Text] [Related]
17. Timely topic: anaplastic lymphoma kinase (ALK) spreads its influence.
Cheuk W; Chan JK
Pathology; 2001 Feb; 33(1):7-12. PubMed ID: 11280613
[TBL] [Abstract] [Full Text] [Related]
18. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract] [Full Text] [Related]
19. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.
Pedersen-Bjergaard J; Ersbøll J; Hansen VL; Sørensen BL; Christoffersen K; Hou-Jensen K; Nissen NI; Knudsen JB; Hansen MM
N Engl J Med; 1988 Apr; 318(16):1028-32. PubMed ID: 3352696
[TBL] [Abstract] [Full Text] [Related]
20. Langerhans cells and their precursors with S100 protein in mycosis fungoides.
Igisu K; Watanabe S; Shimosato Y; Kukita A
Jpn J Clin Oncol; 1983 Dec; 13(4):693-702. PubMed ID: 6196502
[TBL] [Abstract] [Full Text] [Related]
